Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
This approval has come from the company's finished dosage form manufacturing facility
Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.
The approval bolsters the company's Mycophenolate Mofetil portfolio
Juergen Eckhardt joined Bayer in 2016 to help start Leaps by Bayer
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
Guaifenesin extended-release tablets help to loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
The deal represents a total transaction value of up to $36 million with an initial upfront consideration of $14 million
Weinand is the former CEO and Chairman of the Board at Bayer Pharma AG, leading Bayer’s fully integrated $20 billion healthcare business
Oteseconazole Capsules were found to be safe and more effective than fluconazole
Subscribe To Our Newsletter & Stay Updated
